Time of peak drug concentration after a single dose and a dose at steady state

被引:5
作者
Greenberg, HE
England, MJ
Hellriegel, ET
Bjornsson, TD
机构
[1] Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA
[2] Bristol-Myers Squibb P., Princeton, NJ
[3] Division of Clinical Pharmacology, Department of Medicine, Jefferson Medical College, Philadelphia, PA 19107
关键词
D O I
10.1002/j.1552-4604.1997.tb04325.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The time of peak concentration after administration of oral drug is an often quoted and used pharmacokinetic parameter. It is not well appreciated, however, that the peak times after a single dose and a dose at steady state during a multiple administration regimen can differ significantly. This article derives the mathematical relationships that determine how a peak time at steady state differs from that after a single or first dose. These relationships are then evaluated using three different approaches: 1) graphic simulations of time courses of drug concentration for three hypothetical drugs; 2) comparisons of predicted and observed peak times using examples from the literature; and 3) comparisons of predicted and simulated peak times based on different sampling schedules for three hypothetical drugs. The key finding is that peak times after a dose at steady state con occur considerably earlier after administration than after a single dose. However, the manner by which peak times are usually determined, that is, the sampling lime corresponding to the highest measured drug concentration, imposes significant limitations on the usefulness of this parameter.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 15 条
[1]   ESTIMATION OF PHARMACOKINETIC PARAMETERS FOR SIMULATIONS OF TIME COURSES OF DRUG CONCENTRATIONS AFTER ORAL-ADMINISTRATION [J].
BJORNSSON, TD ;
LUI, NL ;
ENGLAND, MJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (11) :1046-1052
[2]  
BJORNSSON TD, 1991, CLIN PHARMACOL THER, V49, P174
[3]  
BJORNSSON TD, 1993, PHARMSIM USERS GUIDE
[4]   PHARMACOKINETIC AND TOLERANCE STUDIES OF CEFPODOXIME AFTER SINGLE-DOSE AND MULTIPLE-DOSE ORAL-ADMINISTRATION OF CEFPODOXIME PROXETIL [J].
BORIN, MT ;
HUGHES, GS ;
PATEL, RK ;
ROYER, ME ;
CATHCART, KS .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (12) :1137-1145
[5]  
DEVANE CL, 1982, PHARMACOL THERAPEUT, V17, P143
[6]  
Gibaldi M. P., 1982, PHARMACOKINETICS
[7]  
Gilman AG, 1990, GOODMAN GILMANS PHAR
[8]  
*MED EC DAT PROD, 1996, PHYS DESK REF
[9]  
SCOTT G, 1992, MELMON MORRELLIS CLI, P1029
[10]   INDENOLOL PHARMACOKINETICS AND PHARMACODYNAMICS AFTER SINGLE AND REPEATED DAILY DOSES [J].
SEGA, R ;
MAILLAND, F ;
COLOMBO, F ;
GROOTHOLD, G ;
PANTAROTTO, C ;
GUENZATI, G ;
LIBRETTI, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (05) :337-342